EUVIMEDEUVIMED entdecken
Crossref

Deciphering the metabolic landscape of MYCN non‐amplified neuroblastoma through integrated multiomics

Lizhi Li, Yaobin Lin, Shan Liu iD, Zhihong Wang iD

The FEBS Journal · 2026-11 · 293 (21) · 6586-6600

DOI: 10.1111/febs.70595 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, online erschienen am 18.06.2026. Verfasst von Lizhi Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Hospital, Fuzhou, China. Hauptthemen laut MEDLINE: Neuroblastoma, N-Myc Proto-Oncogene Protein. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite its clinical importance, the metabolic landscape of MYCN nonamplified neuroblastoma (MYCN‐NA NB) remains poorly defined. In this study, we performed integrated metabolic characterization of 22 NB samples by combining single‐cell RNA sequencing (scRNA‐seq) with proteomics and metabolomics. This was followed by multi‐omics integration, two‐way orthogonal partial least squares analysis, and biomarker selection using a random forest classifier. The scRNA‐seq analysis of NB tumors revealed that, compared to the MYCN‐amplified (MYCN‐A) group, the MYCN‐NA group exhibited higher proportions of T cells, monocytes, and neurons, while lipid metabolism pathways were specifically enriched. Proteomics identified 821 differentially expressed proteins [27 upregulated and 794 downregulated in the high‐risk (HR) NB group], and functional analysis indicated that these proteins were primarily involved in biological processes such as the tricarboxylic acid cycle (TCA) and lipid metabolism. Metabolomics further detected 15 significantly altered metabolites associated with pathways such as linoleic acid metabolism. Integrated multiomics analysis identified key molecules, including RPL9 and POLR2G, with potentially critical roles in HR NB. Multi‐omics correlation and network analyses revealed significant interactions between key proteins (RPL9 and POLR2G) and metabolites (D‐ribose and 9‐oxoODE). The biomarker combination determined by random forest and bidirectional orthogonal partial least squares modeling underscored the central role of oxidative lipid metabolism remodeling in high‐risk disease progression. This study systematically elucidated the crucial role of lipid metabolic reprogramming in the pathogenesis of HR MYCN‐NA NB. These findings provide critical insight for uncovering the mechanisms underlying NB progression and for identifying potential therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaN-Myc Proto-Oncogene ProteinHumansMultiomicsProteomicsGene Expression Regulation, NeoplasticMetabolomicsLipid MetabolismBiomarkers, TumorSingle-Cell Analysis

Stichwörter der Autor:innen

High‐risk neuroblastomaMYCN‐NAmetabolomicsproteomicsscRNA‐seq

Substanzen

N-Myc Proto-Oncogene ProteinMYCN protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Hospital, Fuzhou, China.
  • Department of Radiation Oncology, Fujian Medical University Union Hospital, Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors (Fujian Medical University), Clinical Research Center for Ra…
  • Fujian Children's Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.
  • Department of Hematology, Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Hospital, China.

ORCID-Profile: Shan Liu, Zhihong Wang

Zitieren

APA

Li, L., Lin, Y., Liu, S., & Wang, Z. (2026). Deciphering the metabolic landscape of MYCN non‐amplified neuroblastoma through integrated multiomics. The FEBS Journal, 293(21), 6586-6600. https://doi.org/10.1111/febs.70595

Vancouver

Li L, Lin Y, Liu S, Wang Z. Deciphering the metabolic landscape of MYCN non‐amplified neuroblastoma through integrated multiomics. The FEBS Journal. 2026;293(21):6586-6600. doi:10.1111/febs.70595

BibTeX
@article{Li2026,
  author = {Li, Lizhi and Lin, Yaobin and Liu, Shan and Wang, Zhihong},
  title = {Deciphering the metabolic landscape of MYCN non‐amplified neuroblastoma through integrated multiomics},
  journal = {The FEBS Journal},
  year = {2026},
  volume = {293},
  number = {21},
  pages = {6586--6600},
  doi = {10.1111/febs.70595}
}
Kostenlos starten →